Camilla Holmlund

Contact

camilla.holmlund@umu.se

+46 90 786 77 61

Works at

Staff scientist at Department of Medical Biosciences

By 6M, Sjukhusområdet Umeå universitet, 901 85 Umeå

Publications Publications

LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes

Communications Biology, Springer Nature 2021, Vol. 4, (1)

Herdenberg, Carl; Mutie, Pascal; Billing, Ola; et al.

A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors

Journal of Biological Chemistry, The American Society for Biochemistry and Molecular Biology 2018, Vol. 293, (9) : 3421-3435

Faraz, Mahmood; Herdenberg, Carl; Holmlund, Camilla; et al.

LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease

Lung Cancer, Elsevier 2018, Vol. 125 : 174-184

Karlsson, Terese; Kvarnbrink, Samuel; Holmlund, Camilla; et al.

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma

Oncogenesis, Nature Publishing Group 2018, Vol. 7

Mao, Feng; Holmlund, Camilla; Faraz, Mahmood; et al.

Interactions between LRIG proteins and LMO7 and the expression of LMO7 in human lung cancer.

Cancer Research, Vol. 73, (8: suppl 1) : 5315-

Karlsson, Terese; Kvarnbrink, Samuel; Holmlund, Camilla; et al.

Lrig2-deficient mice are protected against PDGFB-induced glioma

PLOS ONE, Vol. 8, (9) : e73635-

Rondahl, Veronica; Holmlund, Camilla; Karlsson, Terese; et al.

Synergistic killing of Glioblastoma Stem-like cells by Bortezomib and HDAC Inhibitors

Anticancer Research, International Institute of Anticancer Research 2012, Vol. 32, (7 ; Special Issue) : 2407-2413

Asklund, Thomas; Kvarnbrink, Samuel; Holmlund, Camilla; et al.

Synergistic Killing of Glioblastoma Stem-like Cells by Bortezomib and HADC Inhibitors.

Anticancer Research, Vol. 32, (7) : 2407-2413

Asklund, Thomas; Kvarnbrink, Samuel; Holmlund, Camilla; et al.

Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1

Experimental Cell Research, New York: Academic Press 2011, Vol. 317, (4) : 504-512

Yi, Wei; Holmlund, Camilla; Nilsson, Jonas; et al.

Identification and investigations of leucine-rich repeats and immunoglobulin-like domains protein 2 (LRIG2)

Umeå University medical dissertations, 1346

Holmlund, Camilla

Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.

Neuropathology (Kyoto. 1993), Vol. 29, (3) : 242-247

Holmlund, Camilla; Haapasalo, Hannu; Yi, Wei; et al.

Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age

Clinical Neuropathology, Vol. 28, (1) : 21-27

Yi, W; Haapasalo, H; Holmlund, Camilla; et al.

The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in ascidiacea

Genomics, Vol. 84, (1) : 157-165

Guo, Dongsheng; Holmlund, Camilla; Henriksson, Roger; et al.

Characterization and tissue-specific expression of human LRIG2

Gene, Vol. 332 : 35-43

Holmlund, Camilla; Nilsson, Jonas; Guo, Dongsheng; et al.

LRIG2 promotes PDGF induced experimental glioma

Holmlund, Camilla; Casar Borota, Olviera; Miller, J; et al.

Lrig2 knock-out mice have increased mortality, impaired fertility and transiently reduced body weight

Janson, V; Holmlund, Camilla; Vlecken, DH; et al.

LRIG1 is a prognostic biomarker and tumor suppressor in non-small cell lung cancer

Kvarnbrink, Samuel; Karlsson, Terese; Forssell, Joakim; et al.

View publications in DiVA